E-mail this story

FDA approves immune-boosting therapy for prostate cancer

The Food and Drug Administration approved a new immune-boosting therapy for prostate cancer on Thursday, the first therapeutic vaccine for cancer ever approved by the agency. The approval opens the door to a whole new approach to cancer therapy, adding a unique weapon to the arsenal of oncologists.

By Thomas H. Maugh II, Los Angeles Times

April 29, 2010

Send to (as many as 3 e-mail addresses, separated by commas):

Send me a copy.

From:

200 characters remaining